Prediction of Amyloid-beta Pathology in Amnestic Mild Cognitive Impairment with Neuropsychological Tests
Alex Bahar-Fuchs, Victor Villemagne, Kevin Ong, Gael Chetelat, Fiona Lamb, Cornelia B Reininger, Michael Woodward, Christopher C Rowe
Journal of Alzheimer's Disease | IOS PRESS | Published : 2013
Funding support for this study was provided by Bayer Schering Pharma as part of the Imaging A beta in MCI with <SUP>18</SUP>F-Florbetaben project. The funding source had no direct role in the design and conduct of the study, collection, analysis, interpretation of data, or preparation and review of this manuscript. The following people are acknowledged for their support: Greg Savage, Kerryn Pike, Narelle Langdon, Paul Yates, Svetlana Pejoska, Denise El-Sheikh, Rachel Mulligan, and Gareth Jones. We are also grateful to all the individuals who participated in the current study.